THURSDAY, SEPTEMBER 21, 2017

CDC urges travelers to Germany to get measles vaccine

Due to a measles outbreak, the Centers for Disease Control and Prevention (CDC) recommends that travelers to Germany be sure they have been vaccinated against the disease. Read More »

Study shows GSK vaccine protected children from malaria

RTS,S vaccine could be especially valuable to areas of sub-Saharan Africa, where malaria is endemic. Read More »

University of Texas study suggests hydrogen sulfide combats RSV infection

A recent study conducted by the University of Texas Medical Branch (UTMB) in Galveston suggests that hydrogen sulfide (H2S), a gas that is naturally produced within the human body, can decrease severe respiratory syncytial virus (RSV). Read More »

Cerus presents on pathogen-reduced components at symposium

Cerus Corp. presented its most recent research material at the AAB Symposium on Implementation of Pathogen-Reduced Blood Components in Bethesda, Maryland, this week. Read More »

GlaxoSmithKline’s shingles vaccine protects people over 50

A recent study suggests that GlaxoSmithKline’s (GSK) shingles vaccine, which has Agenus’ QS-21 Stimulon Adjuvant, offers approximately 97 percent protection for people 50 years old and above. Read More »

Seattle BioMed announces rebranding

Seattle BioMed announced yesterday that the organization has rebranded as the Center for Infectious Disease Research. Read More »

Global eradication of polio would enhance individual health

As health professionals continue to fight toward eliminating polio from the world, they have explained how global eradication could impact each individual’s health security. Read More »

Congo adds polio vaccine to immunization schedule

The Republic of Congo (DRC) is celebrating African Vaccination Week by introducing the Inactivated Polio Vaccine (IPV) into its routine immunization schedule, Gavi, the Vaccine Alliance, said on Tuesday. “As long as a child somewhere is not protected against this crippling disease, every child is at risk,” Anuradha Gupta, deputy CEO of Gavi, said. Read More »

GlaxoSmithKline shingles vaccine candidate proves 97.2% effective

GlaxoSmithKline (GSK) recently released detailed information from its randomized phase III study of an investigational shingles vaccine candidate (HZ/su) which shows that the vaccine has proven to be 97.2 percent efficient for all test subjects ages 50 to 70. Read More »

United Christian Hospital confirms tuberculosis infection

A recent announcement from the United Christian Hospital (UCH) has confirmed that a staff member has a tuberculosis (TB) infection Read More »

South Dakota senators urge USDA to combat avian influenza

U.S. Sens. Mike Rounds (R-SD) and John Thune (R-SD) recently mailed a letter to U.S. Department of Agriculture (USDA) Secretary Thomas Vilsack, asking that the USDA provide assistance to control the H5N2 avian influenza virus that has been discovered on poultry farms in the state of South Dakota. Read More »

Americas region first to be officially declared rubella-free

Pan American Health Organization (PAHO) leaders announced a historic milestone in Washington, D.C., on April 29, by declaring the Americas region the world’s first to be rubella-free. Read More »

New York's governor approves Blueprint to End AIDS action plan

New York Gov. Andrew Cuomo approved new guidelines on Wednesday that seek to eliminate the AIDS epidemic in the state by the year 2020. The Blueprint to End AIDS outlines a variety of recommendations, including establishing a single point of access where low-income HIV-positive New York residents can receive enhanced rental assistance, as well as transportation and food allowances. Read More »